Cohort Study of Patients With Type 1 Diabetes

NCT ID: NCT03610984

Last Updated: 2022-07-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

2110 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-10-01

Study Completion Date

2021-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to clarify the underlying hereditary and autoimmune factors that contribute to clinical type 1 diabetes and gain a better understanding of the natural history of the disease.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Type 1 Diabetes Mellitus Structured Education

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intensive structured education group

Regular outpatient visit in every 3 months to these patients. The glucose control and diabetes complication screening will be evaluated in visit. Patients will also be evaluated by specialized psychologists, dietitians and therapists. Diabetes self-management education will be regularly exposed to patients

type 1 diabetes structured education

Intervention Type OTHER

The structured education is based on a regular outpatients visit.It is an education that integrated several diabetes related subjects,which mainly aimed at T1D self-management.

Conventional education group

Outpatients visit to endocrinologists when necessary in a conventional way.

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

type 1 diabetes structured education

The structured education is based on a regular outpatients visit.It is an education that integrated several diabetes related subjects,which mainly aimed at T1D self-management.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. diabetes diagnosed according to the report of WHO (World Health Organization) in 1999;
2. insulin dependence from disease onset,thus diagnosed with type 1 diabetes;
3. all patients gave informed consent to participate in the study and the protocol was approved by the Research Ethics Committee in second Xiangya hospital, Central South University.

Exclusion Criteria

1. secondary diabetes mellitus;
2. pregnant women;
3. malignant disease.
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Second Xiangya Hospital of Central South University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Zhiguang Zhou

Professor,Institute of Metabolism and Endocrinology, The Second Xiangya Hospital and the Diabetes Center, Key Laboratory of Diabetes Immunology, Ministry of Education, Central South University, National Clinical Research Center for Metabolic Diseases.

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Institute of Metabolism and Endocrinology, Second Xiangya Hospital, Central South University

Changsha, Hunan, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

References

Explore related publications, articles, or registry entries linked to this study.

Deng C, Xie Y, Liu F, Tang X, Fan L, Yang X, Chen Y, Zhou Z, Li X. Simplified integration of optimal self-management behaviors is associated with improved HbA1c in patients with type 1 diabetes. J Endocrinol Invest. 2024 Nov;47(11):2691-2699. doi: 10.1007/s40618-024-02357-8. Epub 2024 Apr 11.

Reference Type DERIVED
PMID: 38602658 (View on PubMed)

Zhong T, Li X, Lei K, Tang R, Zhou Z, Zhao B, Li X. CXCL12-CXCR4 mediates CD57+ CD8+ T cell responses in the progression of type 1 diabetes. J Autoimmun. 2024 Feb;143:103171. doi: 10.1016/j.jaut.2024.103171. Epub 2024 Feb 1.

Reference Type DERIVED
PMID: 38306953 (View on PubMed)

Ji X, Zou W, Fan L, Zhou Z, Zhu X, Li X. Insulin resistance-related features are associated with cognitive decline: a cross-sectional study in adult patients with type 1 diabetes. Diabetol Metab Syndr. 2024 Jan 11;16(1):13. doi: 10.1186/s13098-023-01249-w.

Reference Type DERIVED
PMID: 38212850 (View on PubMed)

Huang F, Ji X, Xie Y, Li J, Li X, Zhou Z. Structured nutrition and advanced carbohydrate counting questionnaire for adult type 1 diabetes. Chin Med J (Engl). 2023 Jul 20;136(14):1753-1755. doi: 10.1097/CM9.0000000000002721. Epub 2023 Jun 1. No abstract available.

Reference Type DERIVED
PMID: 37262038 (View on PubMed)

Xie Y, Shi M, Ji X, Huang F, Fan L, Li X, Zhou Z. Insulin resistance is more frequent in type 1 diabetes patients with long disease duration. Diabetes Metab Res Rev. 2023 Sep;39(6):e3640. doi: 10.1002/dmrr.3640. Epub 2023 Apr 8.

Reference Type DERIVED
PMID: 36964977 (View on PubMed)

Chen Y, Xia Y, Xie Z, Zhong T, Tang R, Li X, Zhou Z. The Unfavorable Impact of DR9/DR9 Genotype on the Frequency and Quality of Partial Remission in Type 1 Diabetes. J Clin Endocrinol Metab. 2022 Jan 1;107(1):e293-e302. doi: 10.1210/clinem/dgab589.

Reference Type DERIVED
PMID: 34390338 (View on PubMed)

Zhu S, Liu F, Li J, Guan Y, Meng M, Li X, Zhou Z, Xu R, Li L. Development and validation of a self-management scale of type 1 diabetes for Chinese adults. J Int Med Res. 2020 Aug;48(8):300060520947588. doi: 10.1177/0300060520947588.

Reference Type DERIVED
PMID: 32865059 (View on PubMed)

Li X, Zhong T, Tang R, Wu C, Xie Y, Liu F, Zhou Z. PD-1 and PD-L1 Expression in Peripheral CD4/CD8+ T Cells Is Restored in the Partial Remission Phase in Type 1 Diabetes. J Clin Endocrinol Metab. 2020 Jun 1;105(6):dgaa130. doi: 10.1210/clinem/dgaa130.

Reference Type DERIVED
PMID: 32236416 (View on PubMed)

Xie Y, Liu F, Huang F, Lan C, Guo J, He J, Li L, Li X, Zhou Z. Establishment of a type 1 diabetes structured education programme suitable for Chinese patients: type 1 diabetes education in lifestyle and self adjustment (TELSA). BMC Endocr Disord. 2020 Mar 10;20(1):37. doi: 10.1186/s12902-020-0514-9.

Reference Type DERIVED
PMID: 32151245 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

T1D Cohort Study

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Chinese Endocrinologists Health Education Study
NCT05715307 ACTIVE_NOT_RECRUITING NA
Type 2 Diabetes in Fayoum
NCT03683784 COMPLETED